| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | semaphorin receptor activity | 8.93e-07 | 12 | 133 | 4 | GO:0017154 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.35e-06 | 18 | 133 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 2.36e-05 | 9 | 133 | 3 | GO:0036408 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.40e-05 | 28 | 133 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.05e-04 | 37 | 133 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.24e-04 | 15 | 133 | 3 | GO:0010484 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 1.43e-05 | 8 | 133 | 3 | GO:2000427 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 3.04e-05 | 10 | 133 | 3 | GO:2000425 | |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 4.13e-05 | 2 | 133 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation | 6.59e-05 | 34 | 133 | 4 | GO:0035335 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet-derived growth factor receptor signaling pathway | 9.06e-05 | 14 | 133 | 3 | GO:0010642 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 9.68e-05 | 114 | 133 | 6 | GO:0050772 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 9.78e-07 | 13 | 130 | 4 | GO:0002116 | |
| GeneOntologyCellularComponent | microtubule associated complex | 7.62e-06 | 161 | 130 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | inner dynein arm | 2.73e-05 | 10 | 130 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | DNAH3 ARFGEF2 EVPL ACTN3 DNAH7 PPL EFHC2 KIFAP3 DNAH12 INF2 EHHADH RP1 PLS3 DYNC1H1 KLC3 DMTN | 1.48e-04 | 899 | 130 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | axoneme | 3.19e-04 | 207 | 130 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 3.28e-04 | 208 | 130 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | dynein complex | 3.55e-04 | 54 | 130 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 4.89e-04 | 25 | 130 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 7.90e-04 | 7 | 130 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 8.40e-04 | 317 | 130 | 8 | GO:0032838 | |
| GeneOntologyCellularComponent | supramolecular fiber | DNAH3 ARFGEF2 EVPL ACTN3 DNAH7 PPL EFHC2 KIFAP3 DNAH12 INF2 EHHADH SCN5A RP1 PLS3 DYNC1H1 KLC3 DMTN | 1.03e-03 | 1179 | 130 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | symbiont cell surface | 1.05e-03 | 8 | 130 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 1.05e-03 | 8 | 130 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | supramolecular polymer | DNAH3 ARFGEF2 EVPL ACTN3 DNAH7 PPL EFHC2 KIFAP3 DNAH12 INF2 EHHADH SCN5A RP1 PLS3 DYNC1H1 KLC3 DMTN | 1.11e-03 | 1187 | 130 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | other organism part | 1.34e-03 | 9 | 130 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | nuclear body | NRIP1 VRK1 HDAC5 RAPH1 POLE2 KAT6A BARD1 ZMYM2 JADE1 SMC5 TENM2 SERPINB13 HACE1 PLCB1 | 1.49e-03 | 903 | 130 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | microtubule | DNAH3 ARFGEF2 DNAH7 EFHC2 KIFAP3 DNAH12 EHHADH RP1 DYNC1H1 KLC3 | 1.85e-03 | 533 | 130 | 10 | GO:0005874 |
| GeneOntologyCellularComponent | cytoplasmic region | 1.88e-03 | 360 | 130 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | dendrite | DIP2B DSCAM FAT3 ARFGEF2 TENM2 PTPN6 ATP6AP2 LRP1 CNTNAP4 PPP1R2P1 C4A C4B SYNCRIP | 2.69e-03 | 858 | 130 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DIP2B DSCAM FAT3 ARFGEF2 TENM2 PTPN6 ATP6AP2 LRP1 CNTNAP4 PPP1R2P1 C4A C4B SYNCRIP | 2.74e-03 | 860 | 130 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 2.83e-03 | 94 | 130 | 4 | GO:0000123 | |
| Domain | Plexin_cytopl | 2.83e-07 | 9 | 131 | 4 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 2.83e-07 | 9 | 131 | 4 | IPR013548 | |
| Domain | Plexin | 2.83e-07 | 9 | 131 | 4 | IPR031148 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.19e-06 | 14 | 131 | 4 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.19e-06 | 14 | 131 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.19e-06 | 14 | 131 | 4 | PF08393 | |
| Domain | AAA_8 | 2.19e-06 | 14 | 131 | 4 | PF12780 | |
| Domain | DHC_fam | 2.97e-06 | 15 | 131 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 2.97e-06 | 15 | 131 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.97e-06 | 15 | 131 | 4 | IPR004273 | |
| Domain | IPT | 3.58e-05 | 27 | 131 | 4 | SM00429 | |
| Domain | Semap_dom | 6.28e-05 | 31 | 131 | 4 | IPR001627 | |
| Domain | SEMA | 6.28e-05 | 31 | 131 | 4 | PS51004 | |
| Domain | TIG | 6.28e-05 | 31 | 131 | 4 | PF01833 | |
| Domain | Sema | 6.28e-05 | 31 | 131 | 4 | SM00630 | |
| Domain | Sema | 6.28e-05 | 31 | 131 | 4 | PF01403 | |
| Domain | IPT | 7.14e-05 | 32 | 131 | 4 | IPR002909 | |
| Domain | Plexin_repeat | 7.14e-05 | 32 | 131 | 4 | IPR002165 | |
| Domain | PSI | 7.14e-05 | 32 | 131 | 4 | PF01437 | |
| Domain | Dynein_HC_stalk | 1.16e-04 | 14 | 131 | 3 | IPR024743 | |
| Domain | ATPase_dyneun-rel_AAA | 1.16e-04 | 14 | 131 | 3 | IPR011704 | |
| Domain | MT | 1.16e-04 | 14 | 131 | 3 | PF12777 | |
| Domain | AAA_5 | 1.16e-04 | 14 | 131 | 3 | PF07728 | |
| Domain | OST-HTH/LOTUS_dom | 1.46e-04 | 3 | 131 | 2 | IPR025605 | |
| Domain | OST-HTH | 1.46e-04 | 3 | 131 | 2 | PF12872 | |
| Domain | HTH_OST | 1.46e-04 | 3 | 131 | 2 | PS51644 | |
| Domain | PSI | 2.52e-04 | 44 | 131 | 4 | IPR016201 | |
| Domain | PSI | 3.00e-04 | 46 | 131 | 4 | SM00423 | |
| Domain | Rho_GTPase_activation_prot | 3.87e-04 | 88 | 131 | 5 | IPR008936 | |
| Domain | Anaphylatoxin_comp_syst | 4.82e-04 | 5 | 131 | 2 | IPR018081 | |
| Domain | HAT_MYST-type | 4.82e-04 | 5 | 131 | 2 | IPR002717 | |
| Domain | Anaphylatoxn_comp_syst_dom | 4.82e-04 | 5 | 131 | 2 | IPR001840 | |
| Domain | MOZ_SAS | 4.82e-04 | 5 | 131 | 2 | PF01853 | |
| Domain | MYST_HAT | 4.82e-04 | 5 | 131 | 2 | PS51726 | |
| Domain | ANATO | 1.00e-03 | 7 | 131 | 2 | SM00104 | |
| Domain | Plectin | 1.00e-03 | 7 | 131 | 2 | PF00681 | |
| Domain | ANAPHYLATOXIN_2 | 1.00e-03 | 7 | 131 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.00e-03 | 7 | 131 | 2 | PS01177 | |
| Domain | Plectin_repeat | 1.00e-03 | 7 | 131 | 2 | IPR001101 | |
| Domain | ANATO | 1.00e-03 | 7 | 131 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 1.00e-03 | 7 | 131 | 2 | IPR000020 | |
| Domain | PLEC | 1.00e-03 | 7 | 131 | 2 | SM00250 | |
| Domain | Spectrin_repeat | 1.08e-03 | 29 | 131 | 3 | IPR002017 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.33e-03 | 8 | 131 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 1.33e-03 | 8 | 131 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.33e-03 | 8 | 131 | 2 | IPR019742 | |
| Domain | SPEC | 1.44e-03 | 32 | 131 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.44e-03 | 32 | 131 | 3 | IPR018159 | |
| Domain | EGF_CA | 1.69e-03 | 122 | 131 | 5 | SM00179 | |
| Domain | Tyr_Pase_AS | 1.73e-03 | 73 | 131 | 4 | IPR016130 | |
| Domain | EGF-like_Ca-bd_dom | 1.82e-03 | 124 | 131 | 5 | IPR001881 | |
| Domain | PTPc | 2.03e-03 | 36 | 131 | 3 | SM00194 | |
| Domain | A2M | 2.12e-03 | 10 | 131 | 2 | PF00207 | |
| Domain | A2M_N_2 | 2.12e-03 | 10 | 131 | 2 | IPR011625 | |
| Domain | A2M_comp | 2.12e-03 | 10 | 131 | 2 | IPR011626 | |
| Domain | A2M_recep | 2.12e-03 | 10 | 131 | 2 | PF07677 | |
| Domain | A2M_comp | 2.12e-03 | 10 | 131 | 2 | PF07678 | |
| Domain | A2M_N | 2.12e-03 | 10 | 131 | 2 | PF01835 | |
| Domain | A2M_N | 2.12e-03 | 10 | 131 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.12e-03 | 10 | 131 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.12e-03 | 10 | 131 | 2 | PS00477 | |
| Domain | A2M_N_2 | 2.12e-03 | 10 | 131 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 2.12e-03 | 10 | 131 | 2 | IPR001599 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.56e-03 | 39 | 131 | 3 | PS50055 | |
| Domain | - | 2.56e-03 | 39 | 131 | 3 | 2.120.10.30 | |
| Domain | GFP-like | 2.58e-03 | 11 | 131 | 2 | IPR023413 | |
| Domain | - | 2.58e-03 | 11 | 131 | 2 | 2.40.155.10 | |
| Domain | PTPase_domain | 2.96e-03 | 41 | 131 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 2.96e-03 | 41 | 131 | 3 | PF00102 | |
| Domain | EGF_CA | 3.15e-03 | 86 | 131 | 4 | PF07645 | |
| Domain | TYR_PHOSPHATASE_1 | 3.15e-03 | 86 | 131 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 3.28e-03 | 87 | 131 | 4 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 3.28e-03 | 87 | 131 | 4 | PS50056 | |
| Domain | H15 | 3.62e-03 | 13 | 131 | 2 | SM00526 | |
| Domain | H15 | 3.62e-03 | 13 | 131 | 2 | PS51504 | |
| Domain | - | 4.01e-03 | 92 | 131 | 4 | 3.90.190.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.11e-03 | 46 | 131 | 3 | IPR011042 | |
| Domain | Histone_H1/H5_H15 | 4.20e-03 | 14 | 131 | 2 | IPR005818 | |
| Domain | Ldl_recept_b | 4.20e-03 | 14 | 131 | 2 | PF00058 | |
| Domain | LDLRB | 4.20e-03 | 14 | 131 | 2 | PS51120 | |
| Domain | LY | 4.83e-03 | 15 | 131 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.83e-03 | 15 | 131 | 2 | IPR000033 | |
| Domain | EGF_Ca-bd_CS | 4.84e-03 | 97 | 131 | 4 | IPR018097 | |
| Domain | EGF_CA | 5.21e-03 | 99 | 131 | 4 | PS01187 | |
| Domain | Prot-tyrosine_phosphatase-like | 5.21e-03 | 99 | 131 | 4 | IPR029021 | |
| Domain | ASX_HYDROXYL | 5.39e-03 | 100 | 131 | 4 | PS00010 | |
| Domain | EF_hand_dom | 5.94e-03 | 232 | 131 | 6 | IPR002048 | |
| Domain | Ig_E-set | 6.19e-03 | 104 | 131 | 4 | IPR014756 | |
| Domain | C345C | 6.20e-03 | 17 | 131 | 2 | SM00643 | |
| Domain | EGF | 6.31e-03 | 235 | 131 | 6 | SM00181 | |
| Domain | EGF_3 | 6.31e-03 | 235 | 131 | 6 | PS50026 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.62e-03 | 106 | 131 | 4 | IPR000152 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 6.94e-03 | 18 | 131 | 2 | IPR008930 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 1.34e-05 | 7 | 104 | 3 | MM14685 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 2.13e-05 | 8 | 104 | 3 | M47872 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 2.13e-05 | 8 | 104 | 3 | M27031 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 3.17e-05 | 9 | 104 | 3 | MM15030 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 6.17e-05 | 11 | 104 | 3 | M47874 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 6.17e-05 | 11 | 104 | 3 | MM1430 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 8.18e-05 | 12 | 104 | 3 | MM1368 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.06e-04 | 13 | 104 | 3 | M4732 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.34e-04 | 14 | 104 | 3 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.34e-04 | 14 | 104 | 3 | M7578 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.66e-04 | 15 | 104 | 3 | MM15031 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.66e-04 | 15 | 104 | 3 | M7146 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 2.04e-04 | 16 | 104 | 3 | M16498 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 2.04e-04 | 16 | 104 | 3 | M8245 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 2.46e-04 | 17 | 104 | 3 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 2.46e-04 | 17 | 104 | 3 | MM1369 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 3.47e-04 | 19 | 104 | 3 | M10959 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 4.06e-04 | 20 | 104 | 3 | M917 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 5.35e-04 | 51 | 104 | 4 | MM14967 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 5.42e-04 | 22 | 104 | 3 | M39502 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 6.66e-04 | 54 | 104 | 4 | M42568 | |
| Pubmed | 5.72e-08 | 3 | 135 | 3 | 3902621 | ||
| Pubmed | 5.72e-08 | 3 | 135 | 3 | 8806646 | ||
| Pubmed | Paths reunited: Initiation of the classical and lectin pathways of complement activation. | 5.72e-08 | 3 | 135 | 3 | 19783065 | |
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 5.72e-08 | 3 | 135 | 3 | 11241833 | |
| Pubmed | 1.05e-07 | 12 | 135 | 4 | 25839327 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 1.05e-07 | 12 | 135 | 4 | 21270798 | |
| Pubmed | 1.51e-07 | 13 | 135 | 4 | 10520995 | ||
| Pubmed | 2.11e-07 | 14 | 135 | 4 | 9373155 | ||
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 6190740 | ||
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 11306810 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 2.28e-07 | 4 | 135 | 3 | 25518740 | |
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 6088393 | ||
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 10725340 | ||
| Pubmed | A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. | 2.28e-07 | 4 | 135 | 3 | 8570614 | |
| Pubmed | The human complement system: assembly of the classical pathway C3 convertase. | 2.28e-07 | 4 | 135 | 3 | 6906228 | |
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 19302245 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ASNSD1 DIP2B FNTA POLE2 SMCHD1 SHMT2 EVPL PPL PTPN6 PTPN12 ATP6AP2 LRP1 PGLS IRS2 DUSP10 PLS3 SYNCRIP | 2.55e-07 | 974 | 135 | 17 | 28675297 |
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 3.81e-07 | 16 | 135 | 4 | 18489001 | |
| Pubmed | 4.97e-07 | 17 | 135 | 4 | 11683995 | ||
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 4.97e-07 | 17 | 135 | 4 | 17626059 | |
| Pubmed | 5.69e-07 | 5 | 135 | 3 | 25313870 | ||
| Pubmed | 5.69e-07 | 5 | 135 | 3 | 22689574 | ||
| Pubmed | Formation of high affinity C5 convertase of the classical pathway of complement. | 5.69e-07 | 5 | 135 | 3 | 12878586 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | FLII NRIP1 CHD2 SMC5 DNAH12 CAPN7 NCAPD2 C4A RAI14 C4B IRS2 RP1 | 6.00e-07 | 497 | 135 | 12 | 36774506 |
| Pubmed | Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. | 1.13e-06 | 6 | 135 | 3 | 19480842 | |
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 1.27e-06 | 272 | 135 | 9 | 18187620 | |
| Pubmed | 1.84e-06 | 52 | 135 | 5 | 26633812 | ||
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 1.98e-06 | 7 | 135 | 3 | 19063725 | |
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 1.98e-06 | 7 | 135 | 3 | 19655386 | |
| Pubmed | Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. | 1.98e-06 | 7 | 135 | 3 | 10520994 | |
| Pubmed | 1.98e-06 | 7 | 135 | 3 | 1932742 | ||
| Pubmed | 3.16e-06 | 8 | 135 | 3 | 15661641 | ||
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 3.16e-06 | 8 | 135 | 3 | 10072631 | |
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 3.16e-06 | 8 | 135 | 3 | 22368082 | |
| Pubmed | 4.72e-06 | 9 | 135 | 3 | 19909241 | ||
| Pubmed | PlexinA2 and semaphorin signaling during cardiac neural crest development. | 4.72e-06 | 9 | 135 | 3 | 11688557 | |
| Pubmed | VRK2 ARFGEF2 COG3 INF2 WASHC5 ATP6AP2 RAI14 SCFD1 PCDH7 FAM135A PLXNA1 | 4.73e-06 | 504 | 135 | 11 | 34432599 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 FLII KAT6A ARFGEF2 PLXND1 JADE1 RALGAPA2 AHDC1 PPP1R26 INF2 SCN5A NCAPD2 IRS2 PLXNA1 DYNC1H1 RBM38 | 6.48e-06 | 1105 | 135 | 16 | 35748872 |
| Pubmed | Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development. | 6.73e-06 | 10 | 135 | 3 | 18804103 | |
| Pubmed | 7.87e-06 | 257 | 135 | 8 | 16335952 | ||
| Pubmed | Organizations and gene duplications of the human and mouse MHC complement gene clusters. | 9.22e-06 | 11 | 135 | 3 | 10686478 | |
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 1.23e-05 | 12 | 135 | 3 | 24179230 | |
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 23991118 | ||
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 31690636 | ||
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 28407732 | ||
| Pubmed | 1.23e-05 | 130 | 135 | 6 | 12421765 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DIP2B EPB41L4B ARFGEF2 RALGAPA2 ACE2 PTPRJ PLCB1 PCDH7 FAM135A PLXNA1 PLXNA2 | 1.47e-05 | 569 | 135 | 11 | 30639242 |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.50e-05 | 2 | 135 | 2 | 16565498 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 15998580 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19062096 | ||
| Pubmed | Plexin/neuropilin complexes mediate repulsion by the axonal guidance signal semaphorin 3A. | 1.50e-05 | 2 | 135 | 2 | 10781943 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.50e-05 | 2 | 135 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.50e-05 | 2 | 135 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.50e-05 | 2 | 135 | 2 | 17645767 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12207352 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 27456229 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11062259 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 28790404 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.50e-05 | 2 | 135 | 2 | 27758680 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.50e-05 | 2 | 135 | 2 | 23749435 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.50e-05 | 2 | 135 | 2 | 3037333 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11726230 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.50e-05 | 2 | 135 | 2 | 6950384 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.50e-05 | 2 | 135 | 2 | 8428773 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24638111 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 6019133 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.50e-05 | 2 | 135 | 2 | 21345967 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 9344656 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 2572548 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 2302180 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 10946278 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.50e-05 | 2 | 135 | 2 | 18091514 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 29080553 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.50e-05 | 2 | 135 | 2 | 25339671 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 17728371 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 6149580 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 6149581 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12115608 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 3542363 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 2387317 | ||
| Pubmed | Acetylation of the Cd8 Locus by KAT6A Determines Memory T Cell Diversity. | 1.50e-05 | 2 | 135 | 2 | 27653692 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 16908004 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 7365238 | ||
| Pubmed | The EGF/hnRNP Q1 axis is involved in tumorigenesis via the regulation of cell cycle-related genes. | 1.50e-05 | 2 | 135 | 2 | 29884818 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 7391573 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.50e-05 | 2 | 135 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.50e-05 | 2 | 135 | 2 | 17971229 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 6881182 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 39505971 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.50e-05 | 2 | 135 | 2 | 17921792 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 1.50e-05 | 2 | 135 | 2 | 6978711 | |
| Cytoband | 8p11 | 5.13e-05 | 4 | 135 | 2 | 8p11 | |
| GeneFamily | Plexins | 8.10e-08 | 9 | 93 | 4 | 683 | |
| GeneFamily | Dyneins, axonemal | 8.50e-05 | 17 | 93 | 3 | 536 | |
| GeneFamily | EF-hand domain containing|Plakins | 7.18e-04 | 8 | 93 | 2 | 939 | |
| GeneFamily | Complement system|Sushi domain containing | 8.32e-04 | 36 | 93 | 3 | 492 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 9.20e-04 | 9 | 93 | 2 | 1234 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 3.00e-03 | 16 | 93 | 2 | 66 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.39e-03 | 17 | 93 | 2 | 486 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 3.80e-03 | 18 | 93 | 2 | 812 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | STARD13 NRIP1 SMCHD1 KAT6A BARD1 ZMYM2 TRAPPC8 SMC5 TDRD7 PTPN12 MARF1 KAT6B | 5.15e-06 | 466 | 134 | 12 | M13522 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | FLII PDK2 KAT6A SHMT2 DYRK4 DENND2B PTPN6 ATP6AP2 CAPN7 IRAK4 LRP1 PLCB1 KAT6B | 7.20e-06 | 567 | 134 | 13 | M16909 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STARD13 NRIP1 VRK1 SMCHD1 KAT6A BARD1 ZMYM2 MED1 TRAPPC8 SMC5 DENND2B AHDC1 TDRD7 KIFAP3 PTPN12 KAT6B | 8.14e-06 | 856 | 134 | 16 | M4500 |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 2.13e-05 | 294 | 134 | 9 | M1804 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP | 3.26e-05 | 174 | 134 | 7 | M2038 | |
| Coexpression | HUANG_DASATINIB_SENSITIVITY_UP | 5.73e-05 | 80 | 134 | 5 | M3015 | |
| Coexpression | GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP | 5.88e-05 | 191 | 134 | 7 | M3310 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FNTA SMCHD1 KAT6A TRPS1 CHD2 JADE1 MED1 TRAPPC8 SMC5 PRDM1 PTPN6 BCL11B CD8A PTPRJ ATP6AP2 IRAK4 GPCPD1 KAT6B DYNC1H1 RBM38 | 7.19e-05 | 1492 | 134 | 20 | M40023 |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP | 7.38e-05 | 198 | 134 | 7 | M5222 | |
| Coexpression | GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP | 7.86e-05 | 200 | 134 | 7 | M4584 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 7.86e-05 | 200 | 134 | 7 | M9205 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | DNAJB12 DSCAM EVPL ACTN3 MED1 TENM2 ANKRD18B ADGRL4 ACE2 BCL11B CNTNAP4 C2 MOBP PLXNA2 DMTN | 8.53e-05 | 930 | 134 | 15 | MM893 |
| Coexpression | DELYS_THYROID_CANCER_UP | 1.01e-04 | 445 | 134 | 10 | M3645 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 9.40e-06 | 175 | 125 | 8 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | THSD7A EPB41L4B FAT3 TRPS1 COG3 TENM2 RBM20 PRDM1 FAP PTPN12 BCL11B CNTNAP4 RXFP1 KAT6B FAM135A SYNCRIP | 3.26e-05 | 836 | 125 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 5.15e-05 | 163 | 125 | 7 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.10e-05 | 118 | 125 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | TRPS1 ARFGEF2 TENM2 PRDM1 BCL11B DIO2 RXFP1 KAT6B PCDH7 SYNCRIP | 1.06e-04 | 390 | 125 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | FAT3 TRPS1 NUF2 DNAH7 DENND2B KIFAP3 ACE2 FAP NCAPD2 LRP1 CYB5D1 KAT6B PCDH7 PLS3 PLXNA2 | 1.12e-04 | 831 | 125 | 15 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.29e-08 | 182 | 134 | 8 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.29e-08 | 182 | 134 | 8 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-06 | 176 | 134 | 7 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-06 | 179 | 134 | 7 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-06 | 181 | 134 | 7 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.50e-06 | 185 | 134 | 7 | d685a5a2e525db2eba449cfa1e5cd54eb36162a8 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.50e-06 | 185 | 134 | 7 | 5d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.50e-06 | 185 | 134 | 7 | 100b5afdf3c6ab07ffc493f7883f5a7b31c59184 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R|COVID-19_Severe / Disease group, lineage and cell class | 1.50e-06 | 185 | 134 | 7 | 30f064ab7c3890e6f419a845276b145112e78f52 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.50e-06 | 185 | 134 | 7 | f3b1907c3b6f930bc161f46efce5e143babab507 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.50e-06 | 185 | 134 | 7 | 44ce50cb99df8ffc50eba311adcf688477618659 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.50e-06 | 185 | 134 | 7 | 17542ccd52a821c9e99b1a7469e80502e764b3fd | |
| ToppCell | COVID-19_Severe-Hematopoietic_R-RBC|COVID-19_Severe / Disease group, lineage and cell class | 1.50e-06 | 185 | 134 | 7 | 3ed6090b822c6d1d400a421236cddc7511743932 | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.61e-06 | 187 | 134 | 7 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-06 | 189 | 134 | 7 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.73e-06 | 189 | 134 | 7 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-06 | 191 | 134 | 7 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-06 | 193 | 134 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.13e-06 | 195 | 134 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.35e-06 | 198 | 134 | 7 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.30e-06 | 154 | 134 | 6 | f78b01c19afcbab6319f61e4d6023ecb3d510d24 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.76e-06 | 159 | 134 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 95 | 134 | 5 | a09443e527d37adb637a66ca857525dab1c39a9b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 167 | 134 | 6 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 167 | 134 | 6 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.20e-05 | 168 | 134 | 6 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 168 | 134 | 6 | b9db0b1e4fe54a1fe79530d15d206155a1bfac39 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.28e-05 | 170 | 134 | 6 | dfef8f79960979335b86b4730f224239b40735d5 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.28e-05 | 170 | 134 | 6 | fb6098137d010175978596bc382e9ecba9c3891e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.33e-05 | 171 | 134 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-05 | 171 | 134 | 6 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-05 | 173 | 134 | 6 | d17e50dc400098374af626803dec1241ec566769 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-05 | 176 | 134 | 6 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-05 | 178 | 134 | 6 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 180 | 134 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 180 | 134 | 6 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 180 | 134 | 6 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 181 | 134 | 6 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-05 | 182 | 134 | 6 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-05 | 184 | 134 | 6 | ca35a3d2b536c8b2bf5c4d635605e5a3ae94a428 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-05 | 186 | 134 | 6 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-05 | 186 | 134 | 6 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_EGR3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-05 | 186 | 134 | 6 | 77b09af860183606a1775eba921e2071e4a7dd4e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.26e-05 | 188 | 134 | 6 | 34873972dff9284dfcd26bb698c9d1df007f1cbb | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.33e-05 | 189 | 134 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-05 | 190 | 134 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.40e-05 | 190 | 134 | 6 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.40e-05 | 190 | 134 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 191 | 134 | 6 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 193 | 134 | 6 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.62e-05 | 193 | 134 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 2.62e-05 | 193 | 134 | 6 | 2ffe44edf2b02d11a7c10513692eb697a10f911e | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 193 | 134 | 6 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.62e-05 | 193 | 134 | 6 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 193 | 134 | 6 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 2.78e-05 | 195 | 134 | 6 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-05 | 196 | 134 | 6 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-05 | 196 | 134 | 6 | a0ba408b802fa6d6e42e6d234b6879fdb1583f81 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-05 | 198 | 134 | 6 | 99be7a7a84199dac598e993a5a0144d9030f13ce | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-05 | 198 | 134 | 6 | bf4e086c3fc924e999b6eaca87d2beee9b9526c2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.03e-05 | 198 | 134 | 6 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.03e-05 | 198 | 134 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 3.03e-05 | 198 | 134 | 6 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.20e-05 | 200 | 134 | 6 | 2441a36d363b799a4692aa697f969cda056c2d60 | |
| ToppCell | distal-3-Hematologic-Platelet/Megakaryocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.20e-05 | 200 | 134 | 6 | f5f5a8b0e4d802d95dc42646dd5e7d7daaad72b4 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.20e-05 | 200 | 134 | 6 | c7bca638229bd4fd2414171e73fa949e36a10a92 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-05 | 200 | 134 | 6 | 510d84bf7a4621b079e5a7330d25e04508c84a49 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3--L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.20e-05 | 200 | 134 | 6 | d841dbe2297c3bf62f49bae5921662cd6a47e5c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 123 | 134 | 5 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.68e-05 | 124 | 134 | 5 | 298ff8bd8f0459f44ce8a8aea889c6f1cf84ac5f | |
| ToppCell | Severe-CD8+_T|World / Disease group and Cell class | 4.16e-05 | 64 | 134 | 4 | 3e7ede6ec5d8b9c4fc6f3aa8fda91fd9b763ef18 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.57e-05 | 140 | 134 | 5 | 276b3fa924176426efb31112ed4d355407f0b218 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.76e-05 | 145 | 134 | 5 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 9.39e-05 | 151 | 134 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.39e-05 | 151 | 134 | 5 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.03e-04 | 154 | 134 | 5 | 511923b27469ea20f8bd82a9ec27119a6e884644 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.09e-04 | 156 | 134 | 5 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 159 | 134 | 5 | c186bf05c61fac348cf41973827cced83fafd58a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 161 | 134 | 5 | ed93cb6c133855a5c244821e1a260aae8ab4df9a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 161 | 134 | 5 | 0089d7bb305c592392791862a3341fc92af8f3e2 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.34e-04 | 163 | 134 | 5 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.38e-04 | 164 | 134 | 5 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | BAL-Severe-cDC_8|Severe / Compartment, Disease Groups and Clusters | 1.38e-04 | 164 | 134 | 5 | e8cbe7e01eca32886eb44e02d5333056b6bebc50 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 165 | 134 | 5 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 165 | 134 | 5 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 1.42e-04 | 165 | 134 | 5 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 165 | 134 | 5 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.46e-04 | 166 | 134 | 5 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 166 | 134 | 5 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 169 | 134 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 169 | 134 | 5 | 700a3a36c379872585204caa6a6cc269b036ae22 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 170 | 134 | 5 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-04 | 170 | 134 | 5 | 67e78e3c1d4cd3c6eaa5d0a9785b6cd8a3b08039 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 170 | 134 | 5 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 173 | 134 | 5 | 807183fc23478da9451906dacd88de4e73112e0d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 173 | 134 | 5 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.77e-04 | 173 | 134 | 5 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 173 | 134 | 5 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 173 | 134 | 5 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| Disease | neuroblastoma | 5.17e-08 | 116 | 131 | 8 | EFO_0000621 | |
| Disease | serum IgG glycosylation measurement | THSD7A DSCAM TRPS1 CHD2 RALGAPA2 ADGRL4 BCL11B EGF KMT5B EHHADH ZNF804B HACE1 RPE65 MOBP | 9.36e-08 | 523 | 131 | 14 | EFO_0005193 |
| Disease | Lupus Erythematosus, Systemic | 1.64e-05 | 71 | 131 | 5 | C0024141 | |
| Disease | phosphatidylcholine 36:4 measurement | 6.65e-05 | 18 | 131 | 3 | EFO_0010382 | |
| Disease | urate measurement, bone density | DSCAM SLC26A5 GRIN2C TENM2 PPL BCL11B PLCB1 C2 SCFD1 KAT6B FAM135A | 1.04e-04 | 619 | 131 | 11 | EFO_0003923, EFO_0004531 |
| Disease | glucose metabolism disease (implicated_via_orthology) | 2.58e-04 | 28 | 131 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | Complement deficiency disease | 4.23e-04 | 33 | 131 | 3 | C0272242 | |
| Disease | hematocrit | ASNSD1 STARD13 NRIP1 RAPH1 TRPS1 DENND2B ADGRL4 BCL11B PTPRJ PLCB1 RAI14 IRS2 RBM38 | 5.80e-04 | 1011 | 131 | 13 | EFO_0004348 |
| Disease | Colon Carcinoma | 6.90e-04 | 9 | 131 | 2 | C0699790 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 9.27e-04 | 43 | 131 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | Epithelioid Cell Uveal Melanoma | 1.05e-03 | 11 | 131 | 2 | EFO_1000244 | |
| Disease | extrapulmonary tuberculosis | 1.25e-03 | 12 | 131 | 2 | MONDO_0000368 | |
| Disease | alcohol consumption measurement | VRK1 VRK2 THSD7A RAPH1 TRPS1 JADE1 MED1 TENM2 BCL11B PTPRJ HACE1 PLCB1 DIO2 PLXNA2 | 1.27e-03 | 1242 | 131 | 14 | EFO_0007878 |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.36e-03 | 49 | 131 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | cortical thickness | DIP2B FLII VRK2 FAT3 TRPS1 ARFGEF2 PLXND1 TENM2 BCL11B LRP1 PCDH7 MOBP PLXNA2 | 1.39e-03 | 1113 | 131 | 13 | EFO_0004840 |
| Disease | fatty acid measurement, fetal genotype effect measurement, breast milk measurement | 1.48e-03 | 13 | 131 | 2 | EFO_0005110, EFO_0007959, EFO_0009092 | |
| Disease | age at first sexual intercourse measurement | 1.66e-03 | 383 | 131 | 7 | EFO_0009749 | |
| Disease | fatty acid measurement, breast milk measurement, parental genotype effect measurement | 1.72e-03 | 14 | 131 | 2 | EFO_0005110, EFO_0005939, EFO_0009092 | |
| Disease | fasting blood glucose measurement | 1.82e-03 | 287 | 131 | 6 | EFO_0004465 | |
| Disease | neuropsychological test | 1.90e-03 | 197 | 131 | 5 | EFO_0003926 | |
| Disease | lung disease severity measurement | 1.93e-03 | 118 | 131 | 4 | EFO_0007744 | |
| Disease | coronary thrombosis, GM11992 | 2.25e-03 | 16 | 131 | 2 | EFO_0001124, EFO_1000883 | |
| Disease | reticulocyte count | TRPS1 FAM117B DENND2B TMX2 CD8A EGF PTPRJ PLCB1 RAI14 C4B IRS2 RBM38 | 2.44e-03 | 1045 | 131 | 12 | EFO_0007986 |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 2.55e-03 | 17 | 131 | 2 | DOID:11984 (is_marker_for) | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 2.83e-03 | 216 | 131 | 5 | EFO_0007925, EFO_0007927 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.18e-03 | 19 | 131 | 2 | C1333991 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 3.18e-03 | 19 | 131 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.18e-03 | 19 | 131 | 2 | C2936783 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 3.57e-03 | 228 | 131 | 5 | EFO_0003948, MONDO_0004975 | |
| Disease | biological sex | 3.70e-03 | 230 | 131 | 5 | PATO_0000047 | |
| Disease | anorexia nervosa | 3.77e-03 | 70 | 131 | 3 | MONDO_0005351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QKYLGKNSKPNELES | 626 | Q9BXU7 | |
| IFPKRKAAYDSNGNV | 281 | Q9HBW9 | |
| KSPKINLNYAGDDLR | 1241 | Q9BXX2 | |
| NYLTSKKSLPLENNG | 306 | Q99728 | |
| AINEKLGQYASPTAK | 686 | P0C0L5 | |
| YAKKLRQAFQGDSIP | 126 | O95336 | |
| KGRPYANQKLFASLL | 1536 | Q9Y6D5 | |
| LKRGANPNIKDIYGN | 121 | A2A2Z9 | |
| LFLSDGKLKSNLYQP | 421 | Q9C0A0 | |
| SSAPYGKNQVQALKD | 326 | P56282 | |
| GSTNNYKSLKPKLEN | 411 | Q8IYA2 | |
| LYLSQNKPKAAEGLD | 71 | P01732 | |
| DSQLGKENKLYSPAR | 141 | Q96QD5 | |
| KQKLASPQPSYAADA | 591 | Q5TGY3 | |
| QNKKSDVYGNDSLIP | 116 | Q8N865 | |
| YEADKNPKSKPSNGL | 396 | P78524 | |
| TSLAQEYKGNLLLKP | 46 | Q6P9G0 | |
| KKGADLNLVDSLGYN | 206 | Q9P0K7 | |
| AKSDKYLKQQQDAPG | 766 | Q5T481 | |
| GRKANVNLAYLGAKP | 101 | Q9H0Z9 | |
| KNPQNYLLGKKETAE | 361 | Q70E73 | |
| LNPFIYSLRNKDIKG | 286 | Q8NGA2 | |
| IPKKSNDSQNRLYGK | 536 | Q9NWS1 | |
| KLNPKTGLIDYNQLA | 196 | P34897 | |
| PNGSSLKNIEKYLRS | 121 | Q8WYB5 | |
| NPYLLQSNKTKGDPL | 271 | Q12913 | |
| AYKQVKLGEDAPNSS | 71 | Q92813 | |
| LGEPSCNKLKNILYN | 101 | A0AUZ9 | |
| KLYLNSNKLDFDGLP | 296 | Q13045 | |
| LYDLVSKLKLPNNGR | 106 | Q9BZ81 | |
| AKNLAAAEGLEPKYQ | 101 | Q96PQ5 | |
| KLNLDGSNYTLLKQG | 3041 | Q07954 | |
| LYNPCLGSADKNSRK | 701 | P06681 | |
| ASDIKLEPNTLNGYK | 551 | Q4FZB7 | |
| DGDKPKILLYSLNLQ | 3146 | Q2LD37 | |
| GLFNYKRLPATDSNK | 366 | Q9Y6W6 | |
| QLEPSDYLKKLASQG | 691 | Q08426 | |
| KADGYNQPDSKRRQT | 566 | O60506 | |
| QNTDKYPFSNLKLAL | 536 | Q5JST6 | |
| KAPNAEDLSYVNRKG | 156 | Q96MB7 | |
| DPRQTFLYKLSNKAG | 1396 | Q9P2D6 | |
| ANLFNKYPALTKPEN | 371 | P13797 | |
| LGKDSPSNKLLYAKD | 1791 | Q9UIW2 | |
| QAAYLAKPGDSLAQA | 311 | O75051 | |
| LGKDSPSNKLLYAKD | 1766 | P51805 | |
| LQLGKDSPTNKLLYA | 1811 | Q9Y4D7 | |
| ADGKNLTKNDLYPNP | 26 | Q9BZD4 | |
| ASKPNGQRYDSVNEK | 956 | O60245 | |
| YAKENGTKLLLTNDP | 236 | P00480 | |
| LRKVDSDLNQKYGPD | 336 | O60437 | |
| KLNSNLDAKYSPAPG | 351 | Q92817 | |
| LVLLLKKGANPNYQD | 81 | Q8IYU2 | |
| LAYTLLNKLGTKNEP | 381 | Q9P265 | |
| AAGNLKLKYPNENED | 1436 | Q6ZR08 | |
| SPKNAGYKNSLERNN | 356 | P48552 | |
| DPNVAKTKNNLASAY | 371 | Q6P597 | |
| NPFIYSLRNKDIKGA | 286 | Q8NGS3 | |
| AATLPNEYKEGKLQA | 1001 | Q2PPJ7 | |
| GDAQALKPLKFSSNQ | 1106 | Q27J81 | |
| ALLKNASLAGAPKYI | 6 | Q15119 | |
| NPFIYSLRNKDVKGA | 286 | Q8NG98 | |
| ADGKLLPNGDYLNVS | 756 | Q9Y4H2 | |
| LKVSNKGLNSYKDPD | 61 | Q92794 | |
| LKDGPLYRLNTKATN | 161 | Q92794 | |
| LEAKQAKNPASPYNL | 281 | O75787 | |
| ALKLFKNQLSPYEQS | 41 | Q9NR20 | |
| LRNPSYIQEAKAKGL | 566 | Q9NPB8 | |
| ALPQYGELLADKQKR | 606 | Q9C0K0 | |
| KQGPVKDAYSLANNP | 556 | Q9Y6W3 | |
| TAAGNLKLKYPEENE | 1611 | Q8TD57 | |
| KGNNSHILLSALKYP | 146 | P01133 | |
| KKQPAYLGGENLELR | 471 | O14647 | |
| AQPAKVNDLAATAYK | 741 | Q96JB2 | |
| RDKENGNNSPLPKYA | 441 | Q6P1L5 | |
| LSNPEKRKQYDQFGD | 161 | Q9NXW2 | |
| AAGNLKLKYPNENEE | 1511 | Q8WXX0 | |
| YNLTLQAKDKGSPQK | 341 | Q8TDW7 | |
| DYSNKALEKGLNPLN | 316 | O14879 | |
| PNAPSLYDNLSKKRG | 111 | Q9NTQ9 | |
| GSTNNYKSLKPKLEN | 461 | Q3MJ40 | |
| VLAKYNPEGKQDILN | 41 | Q9Y6T7 | |
| KNKARSGENPYASID | 771 | Q9BYF1 | |
| SLLYPDKAETKNNPG | 146 | Q9NQ33 | |
| DGKQLPNSYNLEKIT | 136 | Q96P31 | |
| VYNLPANKDGKSVSN | 516 | Q9Y4F3 | |
| EDLLYNLKQRGPNSS | 21 | Q9NWL6 | |
| GPNSSKQLLKSDVNY | 31 | Q9NWL6 | |
| GYAGRSNLPDNLKKL | 2021 | Q14204 | |
| AVAIKKPSGDDRYNQ | 36 | Q9NWZ3 | |
| LYGTSPLNRQKLDSK | 751 | Q9UQL6 | |
| GSTNNYKSLKPKLEN | 461 | A2RUR9 | |
| NQVLGYKDLAAIPKD | 36 | Q08495 | |
| RGKSPAQAELSYLNK | 251 | Q9H329 | |
| AINEKLGQYASPTAK | 686 | P0C0L4 | |
| LLPKLTALLGNDNYK | 386 | Q92845 | |
| GLVNLYNLPGDNKLK | 156 | Q15648 | |
| KLSSGLDIYRNPLKN | 21 | Q8NGG3 | |
| PEKYLALEKNDSQNL | 296 | P56715 | |
| NPFIYSLRNKDLKQG | 286 | Q8NGR8 | |
| NPLLYSLRNKDVKGA | 291 | Q8NGQ4 | |
| YAKNRIGKSEPSNEL | 961 | O60469 | |
| GQKPAYLLILNAKDL | 496 | Q16518 | |
| KYATGKPDQKDLNEN | 836 | Q9Y3M8 | |
| NYNLKVTLPGLKEDS | 901 | A6NHR9 | |
| NNRLKPLTLAYDGDA | 1641 | Q9UPZ6 | |
| LYSNALKRKTGVNPA | 551 | P58743 | |
| KGILQDRGLSKYPNL | 281 | P49354 | |
| NRNYSKSTELPGKNE | 406 | Q05209 | |
| QSAPKENKPYALNSE | 126 | P13521 | |
| LDLQASKKLPDLYGN | 56 | Q14524 | |
| KSNNPLSSELDLKNY | 2461 | Q9NT68 | |
| AKEGPRLSKNQKYSE | 6 | Q13875 | |
| NPFIYSLRNKDVKGA | 286 | Q96RA2 | |
| AIQEYLKAKSGAAQP | 136 | Q5T8A7 | |
| LDSNPSKGKDLYRSN | 256 | O75626 | |
| KGQDDSLLPQNYCKG | 766 | Q8IZU2 | |
| SGGQDLLLYPAKRKQ | 291 | Q8NHU6 | |
| KSKLKSDNENDGYVP | 791 | Q6IE81 | |
| DISDYPKLLANKQSN | 221 | Q9BWV2 | |
| DYAKLRKDDPIGNLN | 206 | Q08043 | |
| YLNPKGDSARAKAQA | 701 | Q15021 | |
| GLPTKDDNLEHYKNS | 666 | Q12884 | |
| DNSIYVLANLGDKKP | 131 | O95498 | |
| YQRAKKLSKAGDNIP | 261 | Q9Y320 | |
| LPQQYPASGENKSKD | 866 | Q9UHF7 | |
| PLYLNTSLKDCAGKN | 581 | A4D1E1 | |
| PYKAAKTALNNTLDL | 306 | Q12768 | |
| EDLQAKILGIPYKNN | 226 | Q9UIV8 | |
| KDLKELSQLNLSYNP | 316 | Q9HBX9 | |
| YKKALTDAGCNLNPL | 476 | Q8WVM8 | |
| GNKPDALGLNTRLYK | 341 | O75310 | |
| EKYEPNNSLARKGQI | 276 | Q9NQ66 | |
| GDIKASNLLLNYKNP | 176 | Q99986 | |
| YIKNQLLGPDENAKT | 306 | P29350 | |
| LSLYEDKQNPTKGAL | 406 | Q9UBW7 | |
| KSINDLKNTSGLLYP | 401 | Q9Y2L5 | |
| NAKDDLPGVYQKLLD | 91 | Q6PGP7 | |
| GNKPDALGLNTRLYK | 341 | Q9BY64 | |
| ADKAPSRSLNELKQY | 546 | Q8IY18 | |
| DIKAANLLLGYKNPD | 166 | Q86Y07 | |
| SGLSDKKFQRPQDQY | 661 | Q14957 |